New scan aims to see cancer more clearly during treatment
NCT ID NCT06828588
Summary
This study is testing a new imaging tracer called [68Ga]Ga-ABY-025 to see if it can help doctors better identify and visualize tumors in patients receiving standard HER2-targeted cancer therapy. It will involve about 30 adults with advanced HER2-positive cancers who are undergoing or planning to start treatment. The main goal is to check the safety of the new tracer and see if it provides useful images, not to test a new treatment for the cancer itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.